Search

Search Constraints

You searched for: Author/Creator Joner, Michael

Search Results

1. A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A). Issue 3 (18th November 2021)

2. Angiographic performance of everolimus‐eluting stents for the treatment of coronary in‐stent restenosis in daily practice. Issue 5 (26th August 2020)

3. Are we curing one evil with another? A translational approach targeting the role of neoatherosclerosis in late stent failure. (29th April 2020)

4. Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement. Issue 2 (19th October 2022)

5. Back Cover: The Integrin Ligand c(RGDf(NMe)Nal) Reduces Neointimal Hyperplasia in a Polymer‐Free Drug‐Eluting Stent System (ChemMedChem 7/2014). Issue 7 (July 2014)

6. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation. Issue 2 (February 2023)

7. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. (22nd May 2018)

8. Coexistence of calcified- and lipid-containing plaque components and their association with incidental rupture points in acute coronary syndrome-causing culprit lesions: results from the prospective OPTICO-ACS study. (14th December 2021)

9. Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 (ISAR-DESIRE 3 and ISAR-DESIRE 4) trials. (1st February 2018)

10. Comparison of a Drug‐Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3‐Year Follow‐Up. Issue 6 (June 2017)